| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 09/18/2008 | US20080227828 Aryl Ureas With Angiogenisis Inhibiting Activity |
| 09/18/2008 | US20080227789 5-(quinoxalin-2-yl)-N2-(3,4,5-trimethoxyphenyl)thiazole-2,4-diamine; useful in inhibiting the activity of the receptor protein tyrosine kinase Axl; rheumatoid arthritis, vascular disease, vascular injury, psoriasis, visual impairment due to macular degeneration, diabetic retinopathy, retinopathy |
| 09/18/2008 | US20080227776 inhibiting heme-induced lipid peroxidation; preventing isoprostane-mediated tissue damage |
| 09/18/2008 | US20080227770 Benzoxazepine Compound |
| 09/18/2008 | US20080227756 Administering a bisphosphonate until the bone mineral density is within a normal range, interrupting administration to enable the development of the sectional momentum of inertia, and resuming administration when the bone mineral density falls by 5-10% of the normal range |
| 09/18/2008 | US20080227755 Treatment of rheumatoid arthritis by intermittently administering a bisphosphonate; the period between administrations is 2-4 months |
| 09/18/2008 | US20080227747 Composition and methods for treating or preventing degenerative joint and cardiovascular conditions |
| 09/18/2008 | US20080227724 3-(alkanoyl or alkenoyl)amino-caprolactams; autoimmune diseases, asthma, osteoporosis, transplant rejection, psoriasis, Alzheimer's Disease, Multiple sclerosis, ALS; antitumor, antiarthritic, antifibrotic, and antiscarring agents |
| 09/18/2008 | US20080227698 oligopeptide antagonizes binding of DKK1 to LRP5 when in contact with LRP5; degenerative bone diseases |
| 09/18/2008 | US20080227138 Identifying sclerostin antagonist via abilty to prevent apoptosis; treating osteoporosis |
| 09/18/2008 | US20080227135 Autoimmune Conditions and NADPH Oxidase Defects |
| 09/18/2008 | US20080226754 Mammalian articular cartilage disorders, inflammatory joint disease, trauma-related cartilage injuries, and degenerative disc disease |
| 09/18/2008 | US20080226737 Use of Calcitonin For the Treatment of Ra |
| 09/18/2008 | US20080226718 Indole and Azaindole Derivatives For the Treatment of Inflammatory and Autoimmune Diseases |
| 09/18/2008 | US20080226707 WNT compositions and methods of use thereof |
| 09/18/2008 | US20080226692 Cultured Cell Sheet, Production Method Thereof, and Application Method Thereof |
| 09/18/2008 | US20080226683 Potentiating clinoptilolite via saline wash and drying; medicant filler materials; removing metals, nitrates and toxins from organ tissues |
| 09/18/2008 | US20080226654 Uses of mammalian cytokine; related reagents |
| 09/18/2008 | US20080226640 Mixture comprising serum complement system protein (INSP162) use in preparation of vaccines and antibodies for treatment and prevention of infcetion, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders |
| 09/18/2008 | US20080226613 Using chronic inflammation as evaluative tool in predicting and detecting metastatic cancer |
| 09/18/2008 | US20080226612 Compositions of Cells Enriched for Combinations of Various Stem and Progenitor Cell Populations, Methods of Use Thereof and Methods of Private Banking Thereof |
| 09/18/2008 | US20080226611 Using vector transformation to generate transgenic connective tissues for use in treatment of degenerative joint diseases |
| 09/18/2008 | US20080226599 Methods of treatment involving p21/CIP1 |
| 09/18/2008 | DE102004045187B4 Wirkstoffe zur Überführung von inaktivem TGFb-latent in aktiven TGFb und deren Verwendung in kosmetischen und pharmazeutischen Zusammensetzungen Agents for the conversion of inactive latent TGFb in active TGFb and their use in cosmetic and pharmaceutical compositions |
| 09/18/2008 | CA2680625A1 Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors |
| 09/18/2008 | CA2679701A1 Aminopyridines useful as inhibitors of protein kinases |
| 09/17/2008 | EP1970072A1 Use of GLP-2 peptides for the treatment of hyperparathyroidism |
| 09/17/2008 | EP1970059A1 Medication with Dobesilat-Calcium for treatment and prophylaxis of tendon disease |
| 09/17/2008 | EP1969951A2 Compositions against inflammatory processes |
| 09/17/2008 | EP1968614A2 Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid |
| 09/17/2008 | EP1968609A2 Pharmaceutical compositions and methods of use of highly lipophilic sulfhydryl compounds |
| 09/17/2008 | EP1968595A2 Methods of treating cancer and other conditions or disease states using l-cytosine nucleoside analogs |
| 09/17/2008 | EP1968568A2 INHIBITORS OF Akt ACTIVITY |
| 09/17/2008 | EP1968563A2 Treatment methods using triaryl methane compounds |
| 09/17/2008 | EP1968499A1 Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects |
| 09/17/2008 | EP1968498A2 Meniscal implant of hyaluronic acid derivatives for treatment of meniscal defects |
| 09/17/2008 | EP1968400A1 High-potency sweetener composition with calcium and compositions sweetened therewith |
| 09/17/2008 | EP1411968B1 Glp-1 exendin-4 peptide analogs and uses thereof |
| 09/17/2008 | EP1307450B1 2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido(2,3-d)pyrimidin-7-ones |
| 09/17/2008 | EP1245676B1 Human monoclonal antibodies against tgf-beta ii receptor and medicinal use thereof |
| 09/17/2008 | EP1200555B1 Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
| 09/17/2008 | EP0712303B2 Skin patches comprising testosterone and optionally estrogen |
| 09/17/2008 | CN101268096A Y2 selective receptor agonists for therapeutic interventions |
| 09/17/2008 | CN101268049A Novel piperidine derivatives |
| 09/17/2008 | CN101267836A Single dose use of CD20-specific binding molecules |
| 09/17/2008 | CN101267813A Substituted propanamide derivative and pharmaceutical composition containing the same |
| 09/17/2008 | CN101265285A Immunostimulatory nucleic acid molecules |
| 09/17/2008 | CN101264295A Medicaments assembly for treating gout and its hyperuricemia and preparation thereof |
| 09/17/2008 | CN101264291A Medicaments assembly for treating scapulohumeral periarthritis and preparation thereof |
| 09/17/2008 | CN101264275A Medicated pillow for treating scapulohumeral periarthritis and cervical spondylosis |
| 09/17/2008 | CN101264273A Orally-administered pure Chinese medicine for treating bone fracture and osteosporosis and preparation thereof |
| 09/17/2008 | CN101264256A Chinese medicine capsule for treating intractable pain |
| 09/17/2008 | CN101264243A Chinese medicine for treating rheumatism, rheumatoid, hyperosteogeny and femoral head necrosis |
| 09/17/2008 | CN101264219A Medicaments assembly for clearing heat and removing dampness, dispelling wind evil and relaxing vein and preparation thereof |
| 09/17/2008 | CN101264217A Chinese medicine assembly for nourishing yin and tonifying kidney, promoting qi and promoting blood circulation, and relaxing tendons and collaterals |
| 09/17/2008 | CN101264216A Chinese medicinal composition for treating suppurative osteomyelitis and preparation thereof |
| 09/17/2008 | CN101264215A Medicinal composition for treating acute and chronic urarthritis and preparation thereof |
| 09/17/2008 | CN101264205A Chinese medicinal composition for treating gout and preparation thereof |
| 09/17/2008 | CN101264204A Chinese medicinal composition for inhibiting uric acid and treating gout and preparation thereof |
| 09/17/2008 | CN101264201A Chinese medicinal ointment for treating femoral head necrosis |
| 09/17/2008 | CN101264198A Jinguhuo spraying agent and preparation thereof |
| 09/17/2008 | CN101264195A Compound dragon's blood gel preparations and extraction and preparation technique |
| 09/17/2008 | CN101264191A Medicaments assembly for hyperthermia and detoxification, stagnation tendon, and preparation thereof |
| 09/17/2008 | CN101264188A Orally-administered medicinal liquor for treating rheumatic arthritis and preparation thereof |
| 09/17/2008 | CN101264176A Sangju neck protective pillow and manufacturing method thereof |
| 09/17/2008 | CN101264160A Bone-setting and pain-relieving Chinese medicine composition and preparation thereof |
| 09/17/2008 | CN101264146A Externally-applied Chinese herbal medicine for treating muscle and joint disease and preparation thereof |
| 09/17/2008 | CN101264120A Modern Chinese medicine decoction pieces, barrenwort flavonol glycosides decoction pieces and preparation thereof |
| 09/17/2008 | CN101264103A Application of native copper native copper microbial extracting liquid in preparing medicaments for treating bone fracture |
| 09/17/2008 | CN101264073A Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 09/17/2008 | CN101264072A Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 09/17/2008 | CN101264069A Application of resveratrol derivative in preparing medicine for treating disease relative to immune |
| 09/17/2008 | CN100418977C Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 09/17/2008 | CN100418965C Imidazopyridine derivatives |
| 09/17/2008 | CN100418955C Novel Benzo-fused heterocycles |
| 09/17/2008 | CN100418951C Cycloamine derivative and its use as medicine |
| 09/17/2008 | CN100418582C Microcapsule for promoting bone regeneration and its use |
| 09/17/2008 | CN100418573C External Chinese medicine for treating ankylosing spondylitis |
| 09/17/2008 | CN100418568C Composition of Chinese traditional medicine for dispelling wind-evil, activating collateral flow, strengthening the muscles and bones, preparation method and usage |
| 09/17/2008 | CN100418557C Fracture treating Chinese medicine |
| 09/17/2008 | CN100418553C Preparation for treating osteoporosis and preparation method thereof |
| 09/17/2008 | CN100418533C Pharmaceutical combinations of cox-2 inhibitors and opiates |
| 09/17/2008 | CN100418521C Gusuibu extracts for trvating osteoporosis and method for extracting same |
| 09/16/2008 | US7425637 mitogen-activated protein/extracellular signal-regulated (MAP/ERK)Kinase pathways; 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethoxy)-amide; hyperproliferative diseases; anticarcinogenic and antiinflammatory agent |
| 09/16/2008 | US7425580 (Diaryl-methyl)-malononitriles and their use as estrogen receptor ligands |
| 09/16/2008 | US7425573 Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration |
| 09/16/2008 | US7425567 Inhibitor of phosphodiesterase enzyme, 2-(4-(3-cyclopentyloxy-4-difluoromethoxyphenyl)-4-cyanopiperidin-1-yl)acetic acid monohydrate; treating inflammatory diseases, diabetics, allergic diseases, autoimmune diseases, ocular diseases, osteoporosis, Parkinson's disease, dementia; chemical intermediates |
| 09/16/2008 | US7425566 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 09/16/2008 | US7425563 Excellent poly (ADP-ribose) synthetase inhibitors; various ischemic diseases, inflammatory diseases, neurodegenerative diseases, diabetes, septic shock, cephalic injury; 1,2-Dihydro-4-[4-(dimethylaminomethyl)phenyl]-5-hydroxy-1-oxoisoquinoline |
| 09/16/2008 | US7425560 Thioxanthine derivatives as myeloperoxidase inhibitors |
| 09/16/2008 | US7425555 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 09/16/2008 | US7425554 1,2-di(cyclic)substituted benzene compounds |
| 09/16/2008 | US7425549 Drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis |
| 09/16/2008 | US7425536 Feline hepatocyte growth factor |
| 09/16/2008 | US7425532 Use of alanyl aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 09/16/2008 | US7425331 Protein A methods of use |
| 09/16/2008 | US7425325 binding ligands and proteins comprising amino acid sequences, having high specificity for the receptor zcytor17, used to induce proinflammatory cytokine production, for stimulating the immune system and proliferation and/or development of hematopoietic cells in vitro and in vivo; antibodies |
| 09/16/2008 | CA2480429C Novel therapeutical use of agonist ligands specific to g2a receptor |
| 09/16/2008 | CA2379557C Arylsulphonamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 09/16/2008 | CA2358498C The preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioning |